JP2018527886A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527886A5
JP2018527886A5 JP2017565108A JP2017565108A JP2018527886A5 JP 2018527886 A5 JP2018527886 A5 JP 2018527886A5 JP 2017565108 A JP2017565108 A JP 2017565108A JP 2017565108 A JP2017565108 A JP 2017565108A JP 2018527886 A5 JP2018527886 A5 JP 2018527886A5
Authority
JP
Japan
Prior art keywords
cancer
prognosis
metastasis
characterization
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017565108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527886A (ja
Filing date
Publication date
Priority claimed from GBGB1510684.2A external-priority patent/GB201510684D0/en
Application filed filed Critical
Publication of JP2018527886A publication Critical patent/JP2018527886A/ja
Publication of JP2018527886A5 publication Critical patent/JP2018527886A5/ja
Pending legal-status Critical Current

Links

JP2017565108A 2015-06-17 2016-06-17 転移性疾患の予測的遺伝子シグネチャー Pending JP2018527886A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1510684.2A GB201510684D0 (en) 2015-06-17 2015-06-17 Gene signatures predictive of metastatic disease
GB1510684.2 2015-06-17
PCT/GB2016/051825 WO2016203262A2 (en) 2015-06-17 2016-06-17 Gene signatures predictive of metastatic disease

Publications (2)

Publication Number Publication Date
JP2018527886A JP2018527886A (ja) 2018-09-27
JP2018527886A5 true JP2018527886A5 (https=) 2019-07-04

Family

ID=53784091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017565108A Pending JP2018527886A (ja) 2015-06-17 2016-06-17 転移性疾患の予測的遺伝子シグネチャー

Country Status (8)

Country Link
US (1) US20210254166A1 (https=)
EP (1) EP3310927B1 (https=)
JP (1) JP2018527886A (https=)
CN (1) CN108513587A (https=)
CA (1) CA2989388A1 (https=)
GB (1) GB201510684D0 (https=)
HK (1) HK1246367A1 (https=)
WO (1) WO2016203262A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11341138B2 (en) * 2017-12-06 2022-05-24 International Business Machines Corporation Method and system for query performance prediction
GB201901439D0 (en) * 2019-02-01 2019-03-27 Univ London Method of predicting survival rates for cancer patients
GB201903014D0 (en) * 2019-03-06 2019-04-17 Univ Edinburgh Macrophage markers in cancer
GB201903015D0 (en) * 2019-03-08 2019-04-17 Univ Edinburgh Macrophage expression in breast cancer
US20210225460A1 (en) * 2020-01-21 2021-07-22 Genialis Inc. Evaluating the robustness and transferability of predictive signatures across molecular biomarker datasets
CA3174199A1 (en) 2020-04-09 2021-10-14 Ashraf Hafez Predicting likelihood and site of metastasis from patient records
BR112022024206A2 (pt) 2020-06-29 2023-01-03 Ionis Pharmaceuticals Inc Compostos e métodos para modular plp1
WO2022086914A1 (en) * 2020-10-19 2022-04-28 Temple University - Of The Commonwealth System Of Higher Education Genetic approach to suppress coronaviruses
CN120197220B (zh) * 2025-05-23 2025-08-01 华信咨询设计研究院有限公司 一种基于数据集中度的数据风险评估方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
CA2005589C (en) 1988-12-16 2001-02-06 Akzo Nobel Nv Self-sustained, sequence replication system
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
AU2002215345A1 (en) * 2000-10-13 2002-04-22 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
CA2519630A1 (en) * 2003-03-20 2004-10-07 Dana-Farber Cancer Institute, Inc. Gene expression in breast cancer
US7306910B2 (en) * 2003-04-24 2007-12-11 Veridex, Llc Breast cancer prognostics
EP1815021A2 (en) 2004-11-03 2007-08-08 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
US20140018249A1 (en) * 2006-07-26 2014-01-16 Health Discovery Corporation Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
US20090082218A1 (en) 2007-08-13 2009-03-26 Paul Harkin 3'-Based sequencing approach for microarray manufacture
ES2704645T3 (es) * 2008-12-11 2019-03-19 Univ California Membrana de filtración
US20120245235A1 (en) * 2009-12-01 2012-09-27 Compenda Bioscience, Inc Classification of cancers
CA2836277A1 (en) * 2011-05-17 2012-11-22 Takeda Pharmaceutical Company Limited Pharmaceutical compositions and methods for treating cancer
CA2879557A1 (en) * 2012-07-20 2014-01-23 Diagnocure Inc. Methods, kits and compositions for providing a clinical assessment of prostate cancer

Similar Documents

Publication Publication Date Title
JP2018527886A5 (https=)
KR101562644B1 (ko) 직장결장암용 예후 예측
JP2017507320A5 (https=)
CN102333887B (zh) 用于检测gi癌转移的方法
JP2019516407A5 (https=)
JP2019516406A5 (https=)
JP2010528659A (ja) 肝細胞癌のサブタイプを決定し、肝癌幹細胞を検出するための方法
CN104975099A (zh) Hedgehog抑制剂治疗的生物标志物
JP2013500001A5 (https=)
Eissa et al. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis
JP2017214360A (ja) タキサン療法を用いて乳癌を処置する方法
ES2963390T3 (es) Método para predecir la eficacia de la quimioterapia en pacientes con cáncer de mama
JP7235508B2 (ja) Pd-1免疫チェックポイント阻害剤による治療に対するがんの感受性を予測する方法
US10036070B2 (en) Methods and means for molecular classification of colorectal cancers
Zhao et al. Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis
Ibusuki et al. Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens
Locke et al. Next generation biomarkers in prostate cancer.
CA2989480C (en) Kit and method for the diagnosis/prognosis of idiopathic scoliosis
Sippl et al. The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma multiforme
US20210262036A1 (en) Biomarker for prognosis of colorectal cancer
JP2010523134A (ja) Egfr/csf−1/caix発現に基づき非小細胞肺癌の化学療法計画および生存余命を決定する方法
Pavlič et al. Analyzing the invasive front of colorectal cancer–By punching tissue block or laser capture microdissection?
CN102361990A (zh) 通过监测两种基因的表达的乳腺癌患者的预后
JP2024170603A (ja) 免疫チェックポイント阻害療法からの利益を予測する方法
CN111315897B (zh) 用于黑素瘤检测的方法